Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review …
T Liu, S Li, S Ding, J Qiu, C Ren, J Chen, H Wang… - …, 2023 - thelancet.com
Background Pneumonitis is a common complication for patients with locally advanced non-
small cell lung cancer undergoing definitive chemoradiotherapy (CRT). It remains unclear …
small cell lung cancer undergoing definitive chemoradiotherapy (CRT). It remains unclear …
Pneumonitis risk after chemoradiotherapy with and without immunotherapy in patients with locally advanced non-small cell lung cancer: A systematic review and meta …
C Han, J Qiu, L Bai, T Liu, J Chen, H Wang… - International Journal of …, 2024 - Elsevier
Purpose Chemoradiotherapy (CRT) combined with immune checkpoint inhibitors (ICIs) is
the standard of care for patients with unresectable and locally advanced non-small cell lung …
the standard of care for patients with unresectable and locally advanced non-small cell lung …
The Potential of CD4+ T cells ATP level to indicate the Progression in NSCLC Patients
W Ye, K Hou, W Li, Z Tan, Q Huang, H Lin, Z Deng… - 2023 - researchsquare.com
Purpose A new immune function assessment method (sATP CD4) has been proposed to
monitor the immune suppression status in non-small cell lung cancer (NSCLC) patients after …
monitor the immune suppression status in non-small cell lung cancer (NSCLC) patients after …
[HTML][HTML] Radioonkologie: Personalisierung im Fokus
S Marnitz - healthcare-in-europe.com
Denn auch bei ein-und derselben Tumorart können solche molekular basierten Marker
vorhersagen, ob eine Therapie anschlägt oder nicht. Nun erhalten sie auch zunehmend …
vorhersagen, ob eine Therapie anschlägt oder nicht. Nun erhalten sie auch zunehmend …